Oncology Institute, Inc. (TOI) 10% owner adds 18,000 shares in open-market buy

Rhea-AI Filing Summary

Oncology Institute, Inc. ten percent owner Jorey Chernett purchased 18,000 shares of Common Stock on July 21, 2026 at a weighted average price of $5.27 per share in open-market or private transactions. Following this transaction, Chernett directly owns 10,648,858 shares of Oncology Institute common stock. The reported price reflects multiple trades between $5.27 and $5.28 per share, based on the weighted-average pricing disclosure.

Insider Trade Summary

Net Buyer: 18,000 shares

Net Buy 1 txn

Insider Chernett Jorey

Role 10% Owner

Bought 18,000 shs ($95K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1	18,000	$5.27	$95K

Holdings After Transaction: Common Stock — 10,648,858 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.27 to $5.28, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

Key Figures

Shares purchased: 18,000 shares Weighted average price: $5.27 per share Price range: $5.27–$5.28 per share +1 more

4 metrics

Shares purchased 18,000 shares Common Stock purchased on 2026-07-21 by ten percent owner Jorey Chernett

Weighted average price $5.27 per share Weighted average purchase price for the 18,000 Common Stock shares

Price range $5.27–$5.28 per share Range of individual trade prices for the purchased shares

Shares owned after transaction 10,648,858 shares Direct Common Stock holdings of Jorey Chernett following the purchase

Key Terms

weighted average price, ten percent owner, open market or private transaction

3 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

ten percent owner regulatory

""is_ten_percent_owner": 1"

open market or private transaction financial

"Purchase in open market or private transaction"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/22/2026 - 09:55 AM Accepted by SEC EDGAR 07/22/2026 - 09:55 AM Learn about SEC filing dates

FAQ

What insider transaction did Oncology Institute (TOI) report on July 21, 2026?

On July 21, 2026, ten percent owner Jorey Chernett purchased 18,000 shares of Oncology Institute, Inc. Common Stock. The transaction was reported as a purchase in open-market or private transactions at a weighted average price of $5.27 per share.

How many Oncology Institute (TOI) shares did Jorey Chernett buy and at what price?

Jorey Chernett bought 18,000 shares of Oncology Institute Common Stock at a weighted average price of $5.27 per share. According to the footnote, the individual trades occurred in a price range from $5.27 to $5.28 per share.

What is Jorey Chernett’s total ownership in Oncology Institute (TOI) after this Form 4 transaction?

After the reported purchase, Jorey Chernett directly owns 10,648,858 shares of Oncology Institute, Inc. Common Stock. This total reflects the newly acquired 18,000 shares added to his previously held position, as disclosed in the post-transaction holdings column.

Was the Oncology Institute (TOI) insider trade made under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirming a trading plan. There is no footnote stating that the July 21, 2026 purchase was executed pursuant to a Rule 10b5-1 or similar pre-arranged trading arrangement.

What price range did the Oncology Institute (TOI) insider pay for the purchased shares?

The reported weighted average price was $5.27 per share, with individual trades executed between $5.27 and $5.28 per share. The filer notes that detailed information on each separate purchase price is available upon request to the issuer, any security holder, or the SEC staff.

What type of security did Oncology Institute (TOI) insider Jorey Chernett acquire?

Jorey Chernett acquired Common Stock of Oncology Institute, Inc. The Form 4 classifies the transaction as a non-derivative purchase of 18,000 common shares in open-market or private transactions, rather than through options or other derivative securities.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chernett Jorey

(Last) (First) (Middle)

6222 INDIANWOOD TR.

(Street)

BLOOMFIELD HILLS MICHIGAN 48301

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Oncology Institute, Inc. [ TOI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/21/2026		P		18,000	A	$5.27(1)	10,648,858	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.27 to $5.28, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

	/s/ Jorey Chernett	07/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)